Global NGS Tumor Gene Analysis Software Supply, Demand and Key Producers, 2023-2029

Global NGS Tumor Gene Analysis Software Supply, Demand and Key Producers, 2023-2029

The global NGS Tumor Gene Analysis Software market size is expected to reach $ 4590 million by 2029, rising at a market growth of 16.7% CAGR during the forecast period (2023-2029).

NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.

This report studies the global NGS Tumor Gene Analysis Software demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for NGS Tumor Gene Analysis Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of NGS Tumor Gene Analysis Software that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global NGS Tumor Gene Analysis Software total market, 2018-2029, (USD Million)

Global NGS Tumor Gene Analysis Software total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: NGS Tumor Gene Analysis Software total market, key domestic companies and share, (USD Million)

Global NGS Tumor Gene Analysis Software revenue by player and market share 2018-2023, (USD Million)

Global NGS Tumor Gene Analysis Software total market by Type, CAGR, 2018-2029, (USD Million)

Global NGS Tumor Gene Analysis Software total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global NGS Tumor Gene Analysis Software market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World NGS Tumor Gene Analysis Software market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global NGS Tumor Gene Analysis Software Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global NGS Tumor Gene Analysis Software Market, Segmentation by Type
Non-Small Cell Lung Cancer
Human 6 Gene Mutations
Human 12 Gene Mutations
Other

Global NGS Tumor Gene Analysis Software Market, Segmentation by Application
Hospitals and Health Systems
Research Institute
Other

Companies Profiled:
Roche
Illumina
Thermo Fisher Scientific
BGI Group
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
GTH.O
Golden Helix, Inc
Diatech Pharmacogenetics
ViennaLab Diagnostics GmbH
3D Medicines

Key Questions Answered

1. How big is the global NGS Tumor Gene Analysis Software market?

2. What is the demand of the global NGS Tumor Gene Analysis Software market?

3. What is the year over year growth of the global NGS Tumor Gene Analysis Software market?

4. What is the total value of the global NGS Tumor Gene Analysis Software market?

5. Who are the major players in the global NGS Tumor Gene Analysis Software market?

6. What are the growth factors driving the market demand?